Sign up to The Irish Times Archive (1859 - 2008)My Account »

A LARGE US study has reported serious heart risks with a drug used to treat type 2 diabetes.

An analysis of 56 clinical trials found Avandia, one of number of drugs manufactured by GlaxoSmithKline (GSK) in Cork, increased the chances of a heart attack by 28 to 39 per cent, according to researchers at the Cleveland Clinic in Ohio.